Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.355 USD | +15.97% | +36.18% | +121.05% |
10/05 | Transcript : Humacyte, Inc., Q1 2024 Earnings Call, May 10, 2024 | |
28/03 | Transcript : Humacyte, Inc. - Special Call |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+121.05% | 65Cr | |
+29.79% | 4.82TCr | |
-0.36% | 4.17TCr | |
+43.62% | 4.1TCr | |
-5.31% | 2.88TCr | |
+11.11% | 2.56TCr | |
-22.38% | 1.9TCr | |
+8.70% | 1.29TCr | |
+28.75% | 1.2TCr | |
-2.22% | 1.18TCr |
- Stock Market
- Equities
- HUMA Stock
- News Humacyte, Inc.
- Humacyte Seeks FDA Approval of Bioengineered Tissue for Treatment of Vascular Injuries